国家基本药物基层免费供应可行性分析:以上海市65岁以上老人为例

发布时间：2018-05-11 12:37

本文选题：国家基本药物 + 免费供应　；参考：《中国卫生经济》2015年12期

【摘要】：目的:分析国家基本药物基层免费供应的可行性。方法:以上海市65岁以上老人基层用药现状为基础,测算实行国家基本药物基层免费供应后财政、医保和个人的负担,并结合当前政治、经济、技术和社会因素分析其可行性。结果:2013年上海市基层若实施65岁以上老年人国家基本药物免费供应需要10.25亿~33.18亿元,其中医保负担6.74亿~29.9亿元,财政负担1.02亿~11.31亿元。结论:国家基本药物基层免费供应具备政治和技术上的可行性,财政和医保能够共同从经济上保障该政策的实施,有助于进一步巩固和完善国家基本药物制度。但需加强系统研究,从筹资、支付、组织、监管和行为等层面共同推进国家基本药物制度,保障居民用药需求。
[Abstract]:Objective: to analyze the feasibility of the free supply of basic national drugs at the base level. Methods: Based on the current situation of the basic drug use of the elderly over 65 years old in Shanghai, this paper calculates the financial, medical insurance and individual burden of the basic national basic drug supply after the basic drug supply, and analyzes its feasibility in combination with the current political, economic, technical and social factors. Results: in 2013, Shanghai The free supply of basic drugs for the national basic drugs over the age of 65 years old needs 1 billion 25 million ~33.18 billion yuan, of which the burden of medical insurance is 674 million ~29.9 billion yuan and the financial burden is 102 million ~11.31 billion yuan. Conclusion: the free supply of basic drugs at the basic level of the state has the political and technical feasibility, and the financial and medical insurance can jointly guarantee the policy from the economy. The implementation of the system will help to further consolidate and improve the national basic drug system. However, systematic research should be strengthened to promote the national basic drug system and protect the needs of the residents from the aspects of financing, payment, organization, supervision and behavior.

【作者单位】：上海市医学科学技术情报研究所上海市卫生发展研究中心;上海财经大学公共经济管理学院;复旦大学公共卫生学院;上海市人口与发展研究中心;
【基金】：国家卫生计生委药政司2014年度委托研究课题上海市公共卫生重点学科建设项目(12GWZC0601) 美国中华医学基金会卫生系统研究与政策转化合作项目(11-061)
【分类号】：R95

【相似文献】